Answer
Symkevi in combination with ivacaftor is not recommended for patients with cystic fibrosis who have undergone organ transplantation because it has not been studied in this population.
Sources for this answer
- Symkevi 100 mg/150 mg tablets PLGB 22352/0003Vertex Pharmaceuticals (Europe) Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 14Document updated
Sources checked